AF
DRTS icon

Aquamarine Financial’s Alpha Tau Medical DRTS Stock Holding History

Aquamarine Financial’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.1M Buy
+721,501
New +$5.09M 0.37% 12

Other funds holding DRTS

HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return
DSC
Daytona Street Capital Saint Louis, Missouri $130M AUM
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $102M AUM
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Aquamarine Financial's DRTS Position: Q1 2026 in Review

Aquamarine Financial opened a new position in Alpha Tau Medical (DRTS) in Q1 2026: 721,501 shares worth $5.1M. The stake represents 0.37% of the portfolio and ranks #12 among its holdings.

53 funds tracked by Wall St. Rank hold DRTS as of Q1 2026.

  • Aquamarine Financial held 721,501 shares of Alpha Tau Medical worth $5.1M as of Q1 2026.
  • Alpha Tau Medical was a new Aquamarine Financial position in Q1 2026.
  • Alpha Tau Medical made up 0.37% of Aquamarine Financial's portfolio in Q1 2026, its #12 holding.
  • 53 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q1 2026.

Based on Aquamarine Financial's 13F filing for Q1 2026, filed 15 May 2026.